Researchers affiliated with the Brain Repair Centre are transforming scientific findings into new technologies, new agents and new protocols with great therapeutic and economic potential. They’re working in partnership with industry—and many have launched spin-off companies—to take their innovations to market. Their ultimate goal is to see their innovations in use around the world, improving quality of care and quality of life, while contributing to Nova Scotia’s growing life sciences economy.

For example:

Neurosurgery—BRC-affiliated researchers have worked with the National Research Council to develop the NeuroTouch neurosurgery simulator, which allows neurosurgeons to rehearse delicate brain surgeries virtually to improve the safety and effectiveness of procedures. This technology will also be used to train neurosurgery residents and neurosurgeons seeking to advance their skills.

Neuroprotection—Protecting brain cells is the aim of the BRC-affiliated researchers behind DMF Medical Inc., which is developing new technologies, like ZeroSorb, to prevent the death of brain cells during general anesthesia. Dr. David Roach (Dalhousie's Rowe School of Business), Florentin Wilfart (Dalhousie School of Biomedical Engineering) and Dr. Michael Schmidt (Dalhousie Faculty of Medicine and Capital Health) are working together to fine tune and launch this new technology (photo above).

Brain injury and stroke—BRC-affiliated researchers are developing the Cognitive Repair Kit, which uses scientifically validated brain-training software to help people regain the ability to pay attention after a stroke. Others have launched Mindful Scientific Inc. to commercialize the Halifax Consciousness Scanner, a handheld device that quickly and accurately assesses brain function. This can be used to see if a person has sustained a concussion, for example, or to determine brain activity in an unconscious patient. In March 2013, Mindful Scientific won a spot in the Canadian Technology Accelerator program to take part in an intensive incubator program at the Cambridge Innovation Center in Boston, Massachusetts.

DementiaTreventis Corporation was launched in Halifax by BRC-affiliated researchers to develop diagnostic and therapeutic agents for Alzheimer’s Disease. The therapeutic arm is moving to Toronto in 2013, while the diagnostic arm continues to develop its lead compound in Halifax. Another has launched Dementia-Guide Inc., an online set of tools that provides information and support to people with dementia, and their families.

Vision—Vision researchers affiliated with the BRC work with Heidelberg Engineering to develop advanced retinal imaging technologies that enable the early diagnosis of such potentially blinding diseases as glaucoma and macular degeneration. These technologies are in use all around the world, with the next generation currently being developed in new facilities at the Life Sciences Research Institute.

The Brain Repair Centre is focused on helping more researchers take their ideas from the drawing board to the marketplace. The BRC provides knowledge translation grants to help researchers achieve crucial objectives along the way to commercialization. It also works to build stronger connections between science and business and develop business and entrepreneurial knowledge and skills within the research community.

Monday the 18th. © 2018. All rights reserved.. Bridgewater Media Services